Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
502 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alaska Breast Care and Surgery Llc
Anchorage, Alaska, United States
- Alaska Women'S Cancer Care
Anchorage, Alaska, United States
- Anchorage Oncology Centre
Anchorage, Alaska, United States
- Katmai Oncology Group
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- John L Mcclellan Memorial Veterans Hospital
Little Rock, Arkansas, United States
- Kaiser Permanente-Deer Valley Medical Center
Antioch, California, United States
- Sutter Auburn Faith Hospital
Auburn, California, United States
- Kaiser Permanente-Baldwin Park
Baldwin Park, California, United States
- Kaiser Permanente-Bellflower
Bellflower, California, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- Kaiser Permanente South Bay
Harbor City, California, United States
- Kaiser Permanente-Irvine
Irvine, California, United States
- Loma Linda University Medical Center
Loma Linda, California, United States
- Memorial Medical Center
Modesto, California, United States
- Palo Alto Medical Foundation-Camino Division
Mountain View, California, United States
- Palo Alto Medical Foundation-Gynecologic Oncology
Mountain View, California, United States
- Kaiser Permanente-Oakland
Oakland, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Palo Alto Medical Foundation Health Care
Palo Alto, California, United States
- Stanford Cancer Institute Palo Alto
Palo Alto, California, United States
- Kaiser Permanente - Panorama City
Panorama City, California, United States
- Kaiser Permanente-Richmond
Richmond, California, United States
- Kaiser Permanente Sacramento Medical Center
Sacramento, California, United States
- Kaiser Permanente-South Sacramento
Sacramento, California, United States
- Sutter Medical Center Sacramento
Sacramento, California, United States
- Kaiser Permanente-San Diego Mission
San Diego, California, United States
- Kaiser Permanente-San Diego Zion
San Diego, California, United States
- California Pacific Medical Center-Pacific Campus
San Francisco, California, United States
- Kaiser Permanente-San Francisco
San Francisco, California, United States
- Kaiser Permanente-Santa Teresa-San Jose
San Jose, California, United States
- Stanford Cancer Center South Bay
San Jose, California, United States
- Kaiser Permanente-San Marcos
San Marcos, California, United States
- Kaiser Permanente-San Rafael
San Rafael, California, United States
- Kaiser Permanente Medical Center - Santa Clara
Santa Clara, California, United States
- Palo Alto Medical Foundation-Santa Cruz
Santa Cruz, California, United States
- Kaiser Permanente-Santa Rosa
Santa Rosa, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Aug 2013
- Primary completion
- 26 Mar 2020
- Completion
- 31 Dec 2026
- Last update posted
- 2 Jul 2026
- Registered enrollment
- 349
- Registry id
- NCT01856192
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.